Search Within

Steven M Horwitz

Formats
  1. Meeting Abstract (374)
  2. Journal Article (248)
  3. Review (13)
  4. Guidelines (11)
  5. Research Letter (9)
  6. Book Section (6)
  7. Correspondence (5)
  8. Editorial (4)
  9. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (671)
  2. Department of Medicine (671)
  3. Hematologic Malignancies, Division of (671)
  4. Lymphoma (671)
  5. Population Sciences Research Program (671)
  6. Survivorship Research (173)

More Groups

People
  1. Alison Moskowitz (235)
  2. Andrew Zelenetz (169)
  3. Paul Hamlin (140)
  4. Ariela Noy (139)
  5. David Straus (122)
  6. Maria Palomba (112)

More People

Years
  1. 2025 (18)
  2. 2024 (51)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (53)
  6. 2020 (52)

More Years

Publications
  1. Blood (255)
  2. Journal of Clinical Oncology (64)
  3. Hematological Oncology (38)
  4. Blood Advances (19)
  5. Leukemia and Lymphoma (19)
  6. Annals of Oncology (18)

More Publications

Publishers
  1. American Society of Hematology (277)
  2. American Society of Clinical Oncology (65)
  3. Wiley Blackwell (55)
  4. Elsevier Inc. (34)
  5. Oxford University Press (25)
  6. Taylor & Francis Group (23)

More Publishers

Results (671)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Central nervous system involvement in T-cell lymphomas: A single center experience
    Meeting Abstract

    Gurion, R.; Maragulia, J.; Zelenetz, A. D.; Horwitz, S. M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A targeted mutational landscape of angioimmunoblastic T-cell lymphoma: Association between advanced age and mutations in TET2 and DNMT3A
    Meeting Abstract

    Weigert, O.; Kopp, N.; Bolla, S.; Odejide, O.; Toscano, D.; Lunning, M. A.; Teruya-Feldstein, J.; Louissaint, A.; Rodig, S. J.; Horwitz, S. M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Evaluation of quality of biomarker data capture by peripheral sites in an international, cooperative study: Analysis of 104 cases from the T-cell project
    Meeting Abstract

    Pileri, S. A.; Bellei, M.; Vose, J. M.; Connors, J. M.; Foss, F. M.; Horwitz, S. M.; Montoto, S.; Polliack, A.; Zinzani, P. L.; Zucca, E.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Pralatrexate in relapsed/refractory HTLV-1 associated adult T-cell lymphoma/leukemia: A New York City multi-institutional experience
    Meeting Abstract

    Lunning, M. A.; Gonsky, J.; Ruan, J.; Phillips, A. A.; Pulitzer, M.; Moskowitz, A.; Querfeld, C.; Myskowski, P. L.; Noy, A.; Horwitz, S. M.
    Blood (2012)

    Fulltext@MSK | Save
  • CD30 is a potential therapeutic target in patients with HTLV-1 associated adult T-cell leukemia/lymphoma presenting outside of Japan
    Meeting Abstract

    Lunning, M. A.; Chiu, A.; Feldstein, J. T.; Maragulia, J. C.; Moskowitz, A.; Matasar, M. J.; Straus, D. J.; Noy, A.; Myskowski, P. L.; Zelenetz, A. D.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Prioritizing content in continuing hematologic oncology education: A survey of 51 clinical investigators
    Meeting Abstract

    Love, N.; Horwitz, S. M.; Lonial, S.; Palumbo, A.; Smith, M. R.; Hussein, A. M.; Ziel, K.
    Blood (2012)

    Fulltext@MSK | Save
  • Clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides: A single center experience from Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Li, J. Y.; Pulitzer, M.; Myskowski, P. L.; Dusza, S.; Horwitz, S. M.; Moskowitz, A.; Querfeld, C.
    Blood (2012)

    Fulltext@MSK | Save
  • Brentuximab vedotin demonstrates significant clinical activity in relapsed or refractory mycosis fungoides with variable CD30 expression
    Meeting Abstract

    Krathen, M.; Sundram, U.; Bashey, S.; Sutherland, K.; Salva, K.; Wood, G. S.; Advani, R. H.; Hoppe, R. T.; Reddy, S.; Armstrong, R.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • A phase 2 study of brentuximab vedotin in patients with relapsed or refractory CD30-positive non-Hodgkin lymphomas: Interim results
    Meeting Abstract

    Jacobsen, E. D.; Advani, R. H.; Oki, Y.; Sharman, J.; Horwitz, S. M.; Forero-Torres, A.; O'Connor, O. A.; Shustov, A. R.; Siddiqi, T.; Grove, L. E.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Biomarker quality assurance (QA) findings from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry
    Meeting Abstract

    Hsi, E. D.; Gruver, A. M.; Foss, F. M.; Carson, K. R.; Pinter-Brown, L.; Horwitz, S. M.; Rosen, S. T.; Pro, B.; Federico, M.; Gisselbrecht, C.
    Blood (2012)

    Fulltext@MSK | Save